Pro DEX PE ratio PDEX
Share price divided by earnings per share over the last twelve months, since 2016.
- Today, Oct 23, 2026
- 15.1×
- 10-year median
- 16.6×
- Against its 10-year history
- 35th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 4.8× to 50.1×
- Peer median
- 22.0×
Pro DEX's PE ratio is 15.1× as of Oct 23, 2026: a share price of $62.22 against $4.11 of earnings per share over the last twelve months.
That is below its ten-year median of 16.6×, lower than on 65% of days in the last ten years.
Over that time it ranged from 4.8× in Feb 2018 to 50.1× in Oct 2024.
The median for 10 medical instruments and supplies stocks of a similar size is 22.0×.
PE ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 15.1× | 11.3× | 18.5× |
| 2025 | 11.8× | 9.2× | 32.3× |
| 2024 | 32.0× | 11.9× | 50.1× |
| 2023 | 11.8× | 8.7× | 17.0× |
| 2022 | 15.3× | 11.5× | 23.1× |
| 2021 | 21.3× | 17.1× | 23.6× |
| 2020 | 20.0× | 14.6× | 27.5× |
| 2019 | 17.9× | 12.7× | 27.6× |
| 2018 | 23.0× | 4.8× | 33.3× |
| 2017 | 5.1× | 5.1× | 18.7× |
| 2016 | 15.7× | 14.7× | 64.2× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Pro DEX's size, closest first, today.
| Company | PE ratio |
|---|---|
| PDEXPro DEX | 15.1× |
| UTMDUtah Medical Products | 22.6× |
| INFUInfuSystem | 34.0× |
| EMBCEmbecta | 4.6× |
| KEQUKewaunee Scientific | 11.9× |
| TCMDTactile Systems Technology | 21.9× |
| MDXGMimedx | 97.8× |
| APTAlpha Pro Tech | 13.6× |
| MOVMovado | 17.5× |
| NEPHNephros | 22.1× |
| IRMDIradimed | 47.9× |
| Peer median | 22.0× |
Where Pro DEX ranks
What the PE ratio tells you
Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.
Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.
More on Pro DEX
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.